120 results on '"Robinson, Giles W"'
Search Results
2. Cerebellar Mutism Syndrome and Dentato-Thalamo-Cortical Tract Disruption in Diffusion Tractography Following Surgery for Medulloblastoma
3. Application of the Rotterdam postoperative cerebellar mutism syndrome prediction model in patients undergoing surgery for medulloblastoma in a single institution
4. 1 Ototoxicity and Cognitive Outcomes among Children Treated for Brain Tumors in Infancy
5. 6 Feasibility and Perceived Benefit of an Interdisciplinary Rehabilitation Approach within a Tertiary Pediatric Hematology/Oncology Setting
6. PATH-09. THE IMPACT OF MISMATCH REPAIR DEFICIENCY ON GLIOMAS IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS; A MULTI-CENTRIC, COLLABORATIVE STUDY LED BY THE IRRDC AND GLIOMA TASKFORCE
7. Molecular Classification Improves Therapeutic Options for Infants and Young Children With Medulloblastoma
8. DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts
9. High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experience
10. Elucidating the Function of ABCA13 in SHH-Medulloblastoma
11. Data from Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma
12. Supplementary Data from Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma
13. Data from Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma
14. Supplementary Figure from Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma
15. Supplementary Figure from Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma
16. Supplementary Data from Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma
17. A sellar presentation of a WNT-activated embryonal tumor: further evidence of an ectopic medulloblastoma
18. Pub fees email yes from A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
19. Pub fees email yes from A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
20. Supplementary Figures from Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials
21. Supplementary Figures from Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials
22. Unified rhombic lip origins of group 3 and group 4 medulloblastoma
23. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children’s Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials
24. Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma
25. Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor
26. LGG-22. SJ901: Phase I/II evaluation of single agent mirdametinib (PD-0325901), a brain-penetrant MEK1/2 inhibitor, for the treatment of children, adolescents, and young adults with low-grade glioma (LGG)
27. INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
28. Primary cilia control translation and the cell cycle in medulloblastoma
29. Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients
30. ATRT-22. Outcomes for children with recurrent atypical teratoid rhabdoid tumor: A single institution study with updated molecular and germline analysis
31. MEDB-69. Clinical and molecular meta-analysis of three major medulloblastoma clinical trials (ACNS0331, SJMB03, ACNS0332) uncovers novel strategies to improve risk-stratified therapy
32. Reducing Wait Time in a High-volume Pediatric Neuro-oncology Clinic by Optimizing Process Flow: A Quality Improvement Project
33. Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)
34. The posterior fossa syndrome questionnaire: using science to inform practice
35. Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility
36. Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study
37. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
38. [11C]-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
39. Lorlatinib in a Child with ALK-Fusion–Positive High-Grade Glioma
40. Rare cases of medulloblastoma with hypermutation
41. Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma
42. Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study
43. Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials
44. Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)
45. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma
46. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study
47. Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trial
48. Patient-Derived Orthotopic Xenografts and Cell Lines from Pediatric High-Grade Glioma Recapitulate the Heterogeneity of Histopathology, Molecular Signatures, and Drug Response
49. MBCL-21. GERMLINE ELONGATOR MUTATIONS IN SONIC HEDGEHOG MEDULLOBLASTOMA
50. MBRS-24. FUNCTIONAL CHARACTERIZATION OF IKBKAP/ELP1 AS A NOVEL SHH MEDULLOBLASTOMA PREDISPOSITION GENE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.